MJD 2019 Publications

2019

1. Zaccardi F, Morrison A, Khunti K, Davies MJ.  Reply to Mantovani: “Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes”. Liver Int. 2019 Apr;39(4):780-781. doi: 10.1111/liv.14026. Epub 2019 Jan 7. PMID: 30615269

2. Ray K, Kendall D, Zhao Z, Peng X, Caballero E, Polonsky W, Nordstrom B, Fan L, Curtis B, Davies MJ.  A Multinational Observational Study Assessing Insulin Use: Understanding the Determinants Associated with Progression of Therapy.Diabetes Obes Metab. 2019 May;21(5):1101-1110. doi: 10.1111/dom.13622. Epub 2019 Jan 24. PMID: 30565369

3. Aroda V, Ahmann A, Cariou B, Chow F, Davies MJ, Jódar E, Mehta R, Woo V, Lingvay I.  Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials.  Diabetes Metab. 2019 Oct;45(5):409-418. doi: 10.1016/j.diabet.2018.12.001. Epub 2019 Jan 4. PMID: 30615985

4.Chatterjee S, Khunti K, Davies MJ.  Achieving glycaemic control with concentrated insulin in patients with type 2 diabetes.  Drugs. 2019 Feb;79(2):173-186. doi: 10.1007/s40265-018-1048-6. PMID: 30623349

5. Chatterjee S, Khunti K, Davies MJ.  Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes.  Drugs. 2019 Feb;79(2):187. doi: 10.1007/s40265-019-1063-2. PMID: 30706426

6. Davies MJ, Bain S, Charpentier G, Flacke F, Goyeau H, Woloschak M, Hasslacher C, Vespasiani G, Edelman S.  A randomized controlled, treat-to-target study evaluating the efficacy and safety of insulin glargine 300 U/mL (Gla-300) administered using either device-supported or routine titration in people with type 2 diabetes.  J Diabetes Sci Technol. 2019 Sep;13(5):881-889. doi: 10.1177/1932296818821706. Epub 2019 Jan 15.  PMID: 30646755

7. Hussein H, Zaccardi F, Khunti K, Seidu A, Davies MJ, Gray L.Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis. Diabet Med. 2019 Apr;36(4):444-452. doi: 10.1111/dme.13898. Epub 2019 Jan 30. PMID: 30653708

8. Biddle G, Edwardson C, Rowlands A, Davies MJ, Bodicoat D, Hardeman W, Eborall H, Sutton S, Griffin S, Khunti K, Yates T.  Differences in objectively measured physical activity and sedentary behaviour between White Europeans and South Asians recruited from primary care: Cross-sectional analysis of the PROPELS trial.  BMC Public Health. 2019 Jan 21;19(1):95. doi: 10.1186/s12889-018-6341-5. PMID: 30665392

9. Kar D, Gillies C, Khunti K, Davies MJ, Nath M, Seidu S.  Association of smoking and cardiometabolic parameters with albuminuria in people with Type 2 Diabetes Mellitus: A systematic review and meta-analysis.  Acta Diabetol. 2019 Aug;56(8):839-850. doi: 10.1007/s00592-019-01293-x. Epub 2019 Feb 24. PMID: 30799525

10. Harrington DM, Davies MJ, Bodicoat D, Charles JM, Chudasama YV, Gorely T, Khunti K, Rowlands A, Sherar L, Tudor-Edwards R, Yates T, Edwardson C. A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT. Public Health Res 2019;7(5). doi.org/10.3310/phr07050.

11. Zaccardi F, Nystrup Husemoen L, Thorsted B, Webb D, Paul S, Davies MJ, Khunti K.  Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: an observational study. Nutr Metab Cardiovasc Dis. 2019 May;29(5):481-488. doi: 10.1016/j.numecd.2019.01.006. Epub 2019 Feb 16. PMID: 30940488

12. Russell-Jones D, Dauchy A, Delgado E, Dimitriadis G, Frandsen HA, Popescu L, Schultes B, Strojek K, Bonnemaire M, de Climens AR, Davies MJ.  Take Control: A Randomized Trial Evaluating the Efficacy and Safety of Self- Versus Physician-Managed Titration of Insulin Glargine 300 U/mL (Gla-300) in Patients with Uncontrolled Type 2 Diabetes. Diabetes Obes Metab. 2019 Jul;21(7):1615-1624. doi: 10.1111/dom.13697. Epub 2019 Apr 30. PMID: 30851006

13. Rosenstock J, Allison D, Birkenfeld A, Blicher T, Deenadayalan S, Jacobsen J, Serusclat P, Violante R, Watada H, Davies MJ for the PIONEER 3 investigators.  Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults with Type 2 Diabetes Uncontrolled with Metformin Alone or With Sulfonylurea: the PIONEER 3 Randomized Clinical Trial.  JAMA. 2019 Apr 16;321(15):1466-1480. doi: 10.1001/jama.2019.2942. PMID: 30903796

14.Kloecker D, Zaccardi F, Baldry E, Davies MJ, Khunti K, Webb D.  Efficacy of Low- and Very-Low-Energy Diets in people with Type 2 Diabetes Mellitus: A systematic review and meta-analysis of interventional studies.  Diabetes Obes Metab. 2019 Jul;21(7):1695-1705. doi: 10.1111/dom.13727. Epub 2019 Apr 29 PMID: 30924575

15.Dunkley A, Fitzpatrick C, Gray L, Waheed G, Heller S, Frier B, Davies MJ, Khunti K on behalf of the Primary Care Diabetes Society.  Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: a UK multi-site 12-month prospective observational study. Diabetes Obes Metab. 2019 Jul;21(7):1585-1595. doi: 10.1111/dom.13690. Epub 2019 Apr 4. PMID: 30843327

16.Gulsin G, Brady E, Swarbrick D, Athithan L, Henson J, Levelt E, Yates T, Bodicoat D, Khunti K, Davies MJ, McCann G.  Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study).  BMJ Open. 2019 Mar 30;9(3):e023207. doi: 10.1136/bmjopen-2018-023207. PMID: 30928925

17. Rowlands A, Sherar L, Fairclough S, Edwardson C, Harrington D, Davies MJ, Munir F, Khunti K, Stiles V.  A data-driven, meaningful, easy to interpret, population-independent accelerometer outcome variable for global surveillance.  bioRxiv preprint first posted online Apr. 12, 2019; doi: https://doi.org/10.1101/604694.  (This article is a preprint and has not been peer-reviewed)

18.Rowlands AV, Yates T, Olds TS, Davies MJ, Khunti K, Edwardson C. Wrist-Worn Accelerometer-Brand Independent Posture Classification—Corrigendum.  Medicine & Science in Sports & Exercise: May 2019 - Volume 51 - Issue 5 - p 1088, doi: 10.1249/MSS.0000000000001950.

19.Zaccardi F, Davies MJ, Khunti K, Yates T.  Comparative relevance of physical fitness and adiposity on life expectancy: A UK Biobank observational study.  Mayo Clin Proc. 2019 Jun;94(6):985-994. doi: 10.1016/j.mayocp.2018.10.029. Epub 2019 May 9. PMID: 31079962

20.  Perrin N, Bodicoat D, Davies MJ, Robertson N, Snoek F, Khunti K.  Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: A systematic review and meta-analysis.  Prim Care Diabetes. 2019 Apr 27. pii: S1751-9918(19)30145-7. doi: 10.1016/j.pcd.2019.04.001. [Epub ahead of print]. PMID: 31040069

21.  Razieh C, Khunti K, Davies MJ, Edwardson C, Henson J, Darko N, Comber A, Jones A, Yates T.  Association of depression and anxiety with clinical, sociodemographic, lifestyle and environmental factors in South Asians and white Europeans.  Diabet Med. 2019 Sep;36(9):1158-1167. doi: 10.1111/dme.13986. Epub 2019 Jun 30. PMID: 31081286

22.  Jones P, Bibb R, Davies MJ, Khunti K, McCarthy M, Fong D, Webb D.  A fitting problem: Standardising Shoe Fit Standards to Reduce Related Diabetic Foot Ulcers. Diabetes Res Clin Pract. 2019 Aug;154:66-74. doi: 10.1016/j.diabres.2019.05.017. Epub 2019 May 22. PMID: 31128134

23.  Davies MJ, Russell-Jones D, Barber T, Lavalle- González F, Galstyan G, Zhu D, Baxter M, Dessapt-Baradez C, McCrimmon R.  Glycaemic benefit of iGlarLixi in insulin-naïve type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral anti-hyperglycaemic drugs in the LixiLan-O randomized trial.  Diabetes Obes Metab. 2019 Aug;21(8):1967-1972. doi: 10.1111/dom.13791. Epub 2019 Jun 18. PMID: 31124299

24.  Jendle J, Birkenfeld A, Polonsky W, Silver R, Uusinarkaus K, Hansen T, Håkan-Bloch J, Tadayon S, Davies MJ.  Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials.  Diabetes Obes Metab. 2019 Oct;21(10):2315-2326. doi: 10.1111/dom.13816. Epub 2019 Jul 12.   PMID: 31215727

25.  Jones P, Harrison M, Davies MJ, Khunti K, McCarthy M, Webb D, Berrington R. (2019) The biometric shoe: could 3D printed footwear and machine learning theoretically reduce complications from diabetes? The Diabetic Foot Journal 22(2): 28–31

26.  Rowlands A, Sherar L, Fairclough S, Yates T, Edwardson C, Harrington D, Davies MJ, Munir F, Khunti K, Stiles V.  A data-driven, meaningful, easy to interpret, standardised accelerometer outcome variable for global surveillance. J Sci Med Sport. 2019 Oct;22(10):1132-1138. doi: 10.1016/j.jsams.2019.06.016. Epub 2019 Jul 1. PMID: 31288983

27.  Argyridou S, Zaccardi F, Davies MJ, Khunti K, Yates T.  Relevance of physical function in the association of red and processed meat intake with all–cause, cardiovascular, and cancer mortality.  Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1308-1315. doi: 10.1016/j.numecd.2019.06.019. Epub 2019 Jun 27. PMID: 31377183

28. Aroda V, Buse J, Saugstrup T, Donsmark M, Zacho J, Davies MJ.  Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.  Diabetes Obes Metab. 2019 Oct;21(10):2203-2210. doi: 10.1111/dom.13804. Epub 2019 Jun 30. PMID: 31168921

29.  Gulsin G, Kanagala P, Chan D, Cheng A, Athithan L, Graham-Brown M, Singh A, Yang J, Li Z, Khunti K, Davies MJ, Arnold J, Squire I, Ng L, McCann G.  Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes.  Ther Adv Endocrinol Metab. 2019 Jul 5;10:2042018819861593. doi: 10.1177/2042018819861593. eCollection 2019. PMID: 31308926

30.  Byrne J, Dallosso H, Rogers S, Gray L, Waheed G, Patel P, Gupta P, Doherty Y, Davies MJ, Khunti K.  Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial).  JMIR Res Protoc. 2019 Jul 24;8(7):e13831. doi: 10.2196/13831. PMID: 31342905

31.  Lawson C, Zaccardi F, Squire I, Ling S, Davies MJ, Lam C, Mamas M, Khunti K, Kadam U.  20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study.  Lancet Public Health. 2019 Aug;4(8):e406-e420. doi: 10.1016/S2468-2667(19)30108-2. PMID: 31376859

32.  Gray L, Brady E, Albania O, Edwardson C, Harrington D, Khunti K, Miksza J, Raposo J, Smith E, Vazeou A, Vergara I, Weihrauch-Blüher S, Davies MJ.  Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study.  BMC Endocr Disord. 2019 Jul 25;19(1):79. doi: 10.1186/s12902-019-0410-3. PMID: 31345191

33.  Chudasama Y, Khunti K, Gillies C, Rowlands A, Zaccardi F, Yates T, Davies MJ, Dhalwani N.  Physical Activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. BMC Med. 2019 Jun 12;17(1):108. doi: 10.1186/s12916-019-1339-0. PMID: 31186007

34.  Morrison A, Zaccardi F, Chatterjee S, Brady E, Doherty Y, Robertson N, Hadjiconstantinou M, Daniels L, Hall A, Khunti K, Davies MJ.  Self-compassion, metabolic control and health status in individuals with type 2 diabetes: a UK observational study.  Exp Clin Endocrinol Diabetes. 2019 Jun 3. doi: 10.1055/a-0897-3772. [Epub ahead of print]. PMID: 31158896

35.  Miksza J, Zaccardi F, Kunutsor S, Seidu S, Davies MJ, Khunti K.  Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence.  Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1023-1029. doi: 10.1016/j.numecd.2019.06.022. Epub 2019 Jul 6. PMID: 31383500

36.  Rowlands A, Fairclough S, Yates T, Edwardson C, Davies MJ, Munir F, Khunti K, Stiles V.  Activity intensity, volume & norms: Utility & interpretation of accelerometer metrics. Med Sci Sports Exerc. 2019 Nov;51(11):2410-2422. doi: 10.1249/MSS.0000000000002047. PMID: 31318713

37.  Yates T, Gray L, Edwardson C, Henson J, Khunti K, Davies MJ. Impact of depression and anxiety on change to physical activity following a pragmatic diabetes prevention programme within primary care: pooled analysis from two cluster randomized controlled trials. Diabetes Care. 2019 Oct;42(10):1847-1853. doi: 10.2337/dc19-0400. Epub 2019 Aug 9. PMID: 31399440

38.  Charles J, Harrington D, Davies MJ, Edwardson C, Gorely T, Bodicoat D, Khunti K, Sherar L, Yates T, Tudor-Edwards R.  Micro-costing and a cost-consequence analysis of the ‘Girls Active’ programme: A cluster randomised controlled trial.  PLoS One. 2019 Aug 16;14(8):e0221276. doi: 10.1371/journal.pone.0221276. eCollection 2019. PMID: 31419257

39.  Gorely T, Harrington D, Bodicoat D, Davies MJ, Khunti K, Sherar L, Tudor-Edwards R, Yates T, Edwardson C.  Process evaluation of the school-based Girls Active programme. BMC Public Health. 2019 Aug 29;19(1):1187. doi: 10.1186/s12889-019-7493-7. PMID: 31464592

40.  Rowlands A, Plekhanova T, Yates T, Mirkes E, Davies MJ, Khunti K, Edwardson C. Providing a basis for harmonization of accelerometer-assessed physical activity outcomes across epidemiological datasets. Journal for the Measurement of Physical Behaviour 2 (3), 131-142 Sept 2019. doi.org/10.1123/jmpb.2018-0073.

41.  Edwardson C, Henson J, Biddle S, Davies MJ, Khunti K, Maylor B, Yates T.  ActivPAL and ActiGraph assessed sedentary behavior and cardiometabolic health markers.  Med Sci Sports Exerc. 2020 Feb;52(2):391-397. doi: 10.1249/MSS.0000000000002138. PMID: 31479008

42.  Webb D, Davies MJ, Jarvis J, Seidu S, Khunti K.  The right place for Sulphonylureas today: Part of review the series: Implications of recent CVOTs in Type 2 Diabetes Mellitus.  Diabetes Res Clin Pract. 2019 Nov;157:107836. doi: 10.1016/j.diabres.2019.107836. Epub 2019 Aug 31. PMID: 31479704

43.  Crasto W, Morrison A, Gray L, John E, Jarvis J, Brela J, Khunti K, Troughton J, Mc Nally P, Davies MJ.  The Microalbuminuria Education Medication and Optimisation (MEMO) study: Four years follow up of multifactorial intervention in high risk individuals with type 2 diabetes. Diabet Med. 2020 Feb;37(2):286-297. doi: 10.1111/dme.14134. Epub 2019 Sep 23. PMID: 31505051

44.  Gulsin G, Graham-Brown M, Davies MJ, McCann G.  Emerging glucose-lowering therapies: a guide for cardiologists. Heart. 2020 Jan;106(1):18-23. doi: 10.1136/heartjnl-2019-315758. Epub 2019 Sep 24. PMID: 31551292

45. Sargeant J, Henson J, King J, Khunti K, Davies MJ.  A Review of The Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans.  Endocrinol Metab (Seoul). 2019 Sep;34(3):247-262. doi: 10.3803/EnM.2019.34.3.247. PMID: 31565876

46.  Jones P, Bibb R, Davies MJ, Khunti K, McCarthy M, Webb D, Zaccardi F.  Prediction of diabetic foot ulceration: The value of using microclimate sensor arrays. J Diabetes Sci Technol. 2020 Jan;14(1):55-64. doi: 10.1177/1932296819877194. Epub 2019 Oct 9. PMID: 31596145

47.  Chudasama Y, Zaccardi F, Gillies C, Dhalwani N, Yates T, Rowlands A, Davies MJ, Khunti K.  Leisure-time Physical Activity and Life Expectancy in people with Cardiometabolic Multimorbidity and Depression. J Intern Med. 2020 Jan;287(1):87-99. doi: 10.1111/joim.12987. Epub 2019 Nov 6. PMID: 31602698

48.  Jones P, Mirkes E, Yates T, Edwardson C, Catt M, Davies MJ, Khunti K, Rowlands A.Towards a portable model to discriminate activity clusters from accelerometer data. Sensors (Basel). 2019 Oct 17;19(20). pii: E4504. doi: 10.3390/s19204504. PMID: 31627310

49.  Selvarajah D, Kar D, Khunti K, Davies MJ, Scott A, Walker J, Tesfaye S.  Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019 Dec;7(12):938-948. doi: 10.1016/S2213-8587(19)30081-6. Epub 2019 Oct 14. PMID: 31624024

50.  Miller V, Davies MJ, Etherton-Beer C, McGough S, Schofield D, Jensen J, Watson N.  Increasing patient activation through diabetes self-management education: outcomes of DESMOND in regional Western Australia.  Patient Educ Couns. 2020 Apr;103(4):848-853. doi: 10.1016/j.pec.2019.10.013. Epub 2019 Oct 22. PMID: 31676100

51.  Yates T, Edwardson C, Henson J, Zaccardi F, Khunti K, Davies MJ.  Prospectively reallocating sedentary time: associations with cardiometabolic health.  Med Sci Sports Exerc. 2020 Apr;52(4):844-850. doi: 10.1249/MSS.0000000000002204. PMID: 31688653

52.  Argyridou S, Zaccardi F, Davies MJ, Khunti K, Yates T.  Walking pace improves all-cause and cardiovascular mortality risk prediction: A UK Biobank prognostic study.  Eur J Prev Cardiol. 2019 Nov 7:2047487319887281. doi: 10.1177/2047487319887281. [Epub ahead of print]. PMID: 31698963

53.  Zaccardi F, Franks P, Dudbridge F, Davies MJ, Khunti K, Yates T.  Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: a UK Biobank Study.  Eur J Prev Cardiol. 2019 Nov 12:2047487319885041. doi: 10.1177/2047487319885041. [Epub ahead of print]. PMID: 31711304

54.  Davies MJ, Kristunas C, Alshreef A, Dixon S, Eborall H, Glab A, Huddlestone L, Hudson N, Martin G, Northern A, Patterson M, Pritchard R, Schreder S, Stribling B, Turner J, Gray L.  The impact of an intervention to increase uptake to structured self-management education for people with type 2 diabetes mellitus in primary care (the Embedding Package), compared to usual care, on glycaemic control: study protocol for a mixed methods study incorporating a wait-list cluster randomised controlled trial.  BMC Fam Pract. 2019 Nov 7;20(1):152. doi: 10.1186/s12875-019-1038-0. PMID: 31699046

55.  Brady E, Hall A, Baldry E, Chatterjee S, Daniels L, Edwardson C, Khunti K, Patel M, Henson J, Rowlands A, Smith A, Yates T, Davies MJ.  Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study.  BMJ Open. 2019 Nov 11;9(11):e027773. doi: 10.1136/bmjopen-2018-027773. PMID: 31719069

56.  Griffin S, Rutten G, Khunti K, Witte D, Lauritzen T, Sharp S, Dalsgaard EM, Davies MJ, Irving G, Vos R, Webb D, Wareham N, Sandbaek A.  Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster randomised trial. Lancet Diabetes Endocrinol. 2019 Dec;7(12):925-937. doi: 10.1016/S2213-8587(19)30349-3. PMID: 31748169

57.  Lawson C, Zaccardi F, McCann G, Davies MJ, Kadam U, Khunti K.  Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.  JAMA Netw Open. 2019 Dec 2;2(12):e1916447. doi: 10.1001/jamanetworkopen.2019.16447. PMID: 31790564

58.  Rowlands A, Dawkins N, Edwardson C, Fairclough S, Maylor B, Davies MJ, Harrington D, Khunti K, Yates T.  Enhancing the value of accelerometer-assessed physical activity: meaningful visual comparisons of data-driven translational accelerometer metrics.  Sports Med Open. 2019 Dec 5;5(1):47. doi: 10.1186/s40798-019-0225-9. PMID: 31808014

59.  Gossage-Worrall R, Hind D, Barnard-Kelly KD, Shiers D, Etherington A, Swaby L, Holt RIG, Bradburn M, Saxon D, Swaby L, French P, Pendlebury J, Wright S, Waller G, McCrone P, Morris T, Edwardson C, Khunti K, Davies MJ, Carey M, Doherty Y, Northern A, Barnett J, Laugharne R, Dickens C, Greenwood K, Gaughran F, Kalidindi S, Rathod S, Siddiqi N, Etherington A, Shiers D.  STructured lifestyle education for people WIth SchizophrEnia (STEPWISE): mixed methods process evaluation of a group-based lifestyle education programme to support weight loss in people with schizophrenia.  BMC Psychiatry. 2019 Nov 13;19(1):358. doi: 10.1186/s12888-019-2282-5. PMID: 31722694

60.  Darko N, Dallosso H, Hadjiconstantinou M, Hulley K, Khunti K, Davies MJ.  Qualitative evaluation of A Safer Ramadan, a structured education programme that addresses the safer observance of Ramadan for Muslims with Type 2 diabetes. Diabetes Res Clin Pract. 2020 Feb;160:107979. doi: 10.1016/j.diabres.2019.107979. Epub 2019 Dec 12.  PMID: 31838120

61.  Buse J, Wexler D, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio D, Davies MJ.  2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).  Diabetes Care. 2020 Feb;43(2):487-493. doi: 10.2337/dci19-0066. Epub 2019 Dec 19. PMID: 31857443

62.  Buse J, Wexler D, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio D, Davies MJ. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).  Diabetologia. 2020 Feb;63(2):221-228. doi: 10.1007/s00125-019-05039-w. PMID: 31853556

63.  Mullis R, Aquino M, Dawson S, Johnson V, Jowett S, Kreit E, Mant J, Carey M, Davies MJ, Doherty Y, Khunti K, Lim L, Macintosh B, Mander A, McKevitt C, Roland M, Sutton S, Walker M, Wardburton E.  Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community.  BMJ Open. 2019 Aug 18;9(8):e030285. doi: 10.1136/bmjopen-2019-030285. PMID: 31427339

64.  Narendran P, Quann N, Nagi D, Gallen I, Gorton J, Daly H, Jaicim NB, Davies MJ, Andrews R on behalf of The EXTOD Education research group.  Rationale and methods for the Exercise for Type 1 Diabetes education programme: a pilot randomised controlled trial of an education programme to support adults with type 1 diabetes (T1DM) to undertake exercise. BMJ Open Diab Res Care 2019;7:e000693. doi:10.1136/bmjdrc-2019-000693. 

Share this page:

Navigation

shanghairanking-sm.jpg